Newron Pharmaceuticals SpA (NWRN) — Cash Flow-to-Debt Ratio
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of CHF-1.33 Million could theoretically repay 0% of its total liabilities (CHF51.15 Million) in one year. See cash generation quality of Newron Pharmaceuticals SpA to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Newron Pharmaceuticals SpA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Newron Pharmaceuticals SpA across 21 annual periods. Also explore NWRN net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Newron Pharmaceuticals SpA (2005–2025)
Year-by-year debt coverage analysis for Newron Pharmaceuticals SpA. For market capitalisation and broader financial context, see NWRN stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | CHF32.56 Million | CHF51.15 Million | ▲ +325.7% |
| 2024 | -0.28x | CHF-17.61 Million | CHF62.45 Million | ▼ -55.1% |
| 2023 | -0.18x | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.09 Million | CHF51.23 Million | ▲ +10.4% |
| 2021 | -0.24x | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.94x | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.09x | CHF-15.95 Million | CHF5.16 Million | ▼ -95.0% |
| 2017 | -1.58x | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.86x | CHF-19.58 Million | CHF6.84 Million | ▼ -61.7% |
| 2015 | -1.77x | CHF-12.86 Million | CHF7.27 Million | ▼ -38.3% |
| 2014 | -1.28x | CHF-10.00 Million | CHF7.81 Million | ▼ -26.1% |
| 2013 | -1.02x | CHF-10.69 Million | CHF10.53 Million | ▼ -396.9% |
| 2012 | 0.34x | CHF5.83 Million | CHF17.04 Million | ▲ +148.3% |
| 2011 | -0.71x | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.76x | CHF-19.13 Million | CHF6.94 Million | ▼ -48.1% |
| 2009 | -1.86x | CHF-23.06 Million | CHF12.39 Million | ▼ -37.5% |
| 2008 | -1.35x | CHF-19.93 Million | CHF14.73 Million | ▼ -26.6% |
| 2007 | -1.07x | CHF-13.87 Million | CHF12.97 Million | ▼ -103.2% |
| 2006 | -0.53x | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.21x | CHF-14.33 Million | CHF6.48 Million | — |